{"id":1554,"date":"2020-09-29T16:11:59","date_gmt":"2020-09-29T16:11:59","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1554"},"modified":"2026-02-23T23:38:31","modified_gmt":"2026-02-23T23:38:31","slug":"molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2020\/09\/29\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\/","title":{"rendered":"Molecular landscape of CAPN3 mutations in limb-girdle muscular dystrophy type R1: from a Chinese multicentre analysis to a worldwide perspective (Contributed by Dr. Sushan Luo)"},"content":{"rendered":"

Limb-girdle muscular dystrophy (LGMD) is a group of genetically heterogeneous disorders characterized by progressive proximal limb muscle weakness and dystrophic features in pathology. As the most prevailing subtype of LGMD, LGMD R1 is caused by recessive mutations in CAPN3 gene. Here we performed a retrospective analysis in recessive CAPN3 mutations identified in Chinese cohort and the database-registered CAPN3 mutations to achieve a worldwide perspective. Two hotspot mutations c.2120A>G in Chinese patients and c.550del in European patients were revealed\u00a0 and 25% mutations identified in CAPN3 gene were deleterious. These findings may aid in providing information for future gene therapy development. (https:\/\/jmg.bmj.com\/content\/early\/2020\/09\/28\/jmedgenet-2020-107159<\/a> )<\/p>\n

\"\"<\/a><\/p>\n

The neuromuscular research group in Huashan hospital<\/p>\n","protected":false},"excerpt":{"rendered":"

Limb-girdle muscular dystrophy (LGMD) is a group of genetically heterogeneous disorders characterized by progressive proximal limb muscle weakness and dystrophic features in pathology. As the most prevailing subtype of LGMD, LGMD R1 is caused by recessive mutations in CAPN3 gene. Here we performed a retrospective analysis in recessive CAPN3 mutations identified in Chinese cohort and […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1554","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nMolecular landscape of CAPN3 mutations in limb-girdle muscular dystrophy type R1: from a Chinese multicentre analysis to a worldwide perspective (Contributed by Dr. Sushan Luo) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2020\/09\/29\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Molecular landscape of CAPN3 mutations in limb-girdle muscular dystrophy type R1: from a Chinese multicentre analysis to a worldwide perspective (Contributed by Dr. Sushan Luo) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Limb-girdle muscular dystrophy (LGMD) is a group of genetically heterogeneous disorders characterized by progressive proximal limb muscle weakness and dystrophic features in pathology. As the most prevailing subtype of LGMD, LGMD R1 is caused by recessive mutations in CAPN3 gene. Here we performed a retrospective analysis in recessive CAPN3 mutations identified in Chinese cohort and [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2020\/09\/29\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-29T16:11:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-23T23:38:31+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/09\\\/29\\\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/09\\\/29\\\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Molecular landscape of CAPN3 mutations in limb-girdle muscular dystrophy type R1: from a Chinese multicentre analysis to a worldwide perspective (Contributed by Dr. Sushan Luo)\",\"datePublished\":\"2020-09-29T16:11:59+00:00\",\"dateModified\":\"2026-02-23T23:38:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/09\\\/29\\\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\\\/\"},\"wordCount\":142,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/09\\\/29\\\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/09\\\/29\\\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/09\\\/29\\\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\\\/\",\"name\":\"Molecular landscape of CAPN3 mutations in limb-girdle muscular dystrophy type R1: from a Chinese multicentre analysis to a worldwide perspective (Contributed by Dr. Sushan Luo) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2020-09-29T16:11:59+00:00\",\"dateModified\":\"2026-02-23T23:38:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/09\\\/29\\\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/09\\\/29\\\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2020\\\/09\\\/29\\\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Molecular landscape of CAPN3 mutations in limb-girdle muscular dystrophy type R1: from a Chinese multicentre analysis to a worldwide perspective (Contributed by Dr. Sushan Luo)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Molecular landscape of CAPN3 mutations in limb-girdle muscular dystrophy type R1: from a Chinese multicentre analysis to a worldwide perspective (Contributed by Dr. Sushan Luo) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2020\/09\/29\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\/","og_locale":"en_US","og_type":"article","og_title":"Molecular landscape of CAPN3 mutations in limb-girdle muscular dystrophy type R1: from a Chinese multicentre analysis to a worldwide perspective (Contributed by Dr. Sushan Luo) - JMG Contact blog","og_description":"Limb-girdle muscular dystrophy (LGMD) is a group of genetically heterogeneous disorders characterized by progressive proximal limb muscle weakness and dystrophic features in pathology. As the most prevailing subtype of LGMD, LGMD R1 is caused by recessive mutations in CAPN3 gene. Here we performed a retrospective analysis in recessive CAPN3 mutations identified in Chinese cohort and [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2020\/09\/29\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\/","og_site_name":"JMG Contact blog","article_published_time":"2020-09-29T16:11:59+00:00","article_modified_time":"2026-02-23T23:38:31+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2020\/09\/29\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2020\/09\/29\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Molecular landscape of CAPN3 mutations in limb-girdle muscular dystrophy type R1: from a Chinese multicentre analysis to a worldwide perspective (Contributed by Dr. Sushan Luo)","datePublished":"2020-09-29T16:11:59+00:00","dateModified":"2026-02-23T23:38:31+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2020\/09\/29\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\/"},"wordCount":142,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2020\/09\/29\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2020\/09\/29\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\/","url":"https:\/\/blogs.bmj.com\/jmg\/2020\/09\/29\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\/","name":"Molecular landscape of CAPN3 mutations in limb-girdle muscular dystrophy type R1: from a Chinese multicentre analysis to a worldwide perspective (Contributed by Dr. Sushan Luo) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2020-09-29T16:11:59+00:00","dateModified":"2026-02-23T23:38:31+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2020\/09\/29\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2020\/09\/29\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2020\/09\/29\/molecular-landscape-of-capn3-mutations-in-limb-girdle-muscular-dystrophy-type-r1-from-a-chinese-multicentre-analysis-to-a-worldwide-perspective\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Molecular landscape of CAPN3 mutations in limb-girdle muscular dystrophy type R1: from a Chinese multicentre analysis to a worldwide perspective (Contributed by Dr. Sushan Luo)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1554","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1554"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1554\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1554"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1554"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1554"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}